Spiramide and Hydroquinidine Inhibit Proliferation and Migration While Promoting Apoptosis and Oxidative Stress in Neuroblastoma Cells
International Journal of Molecular Sciences · 17.07.2026 · 27 (14) · 6367
DOI: 10.3390/ijms27146367 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2026. Verfasst von Evren Gümüş und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Department, School of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Cell Proliferation, Cell Movement, Neuroblastoma. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroblastoma is an aggressive pediatric malignancy with limited therapeutic options for high-risk disease, underscoring the need for alternative treatment strategies. Drug repurposing offers a promising approach to accelerate the identification of effective anti-cancer agents. In this study, we investigated the anti-carcinogenic effects of hydroquinidine, a class IA antiarrhythmic ion channel blocker, and spiramide, a dopamine D2/serotonin 5-HT2 receptor antagonist and endoplasmic reticulum stress inducer, in SH-SY5Y human neuroblastoma cells. Cells were treated with increasing concentrations of each compound and evaluated using cell viability, colony formation, wound healing, proliferation, apoptosis, and quantitative gene expression assays. Both compounds induced a dose-dependent reduction in cell viability, with spiramide exhibiting greater potency than hydroquinidine. Functional assays revealed significant suppression of clonogenic survival, cell migration, and DNA synthesis, accompanied by increased oxidative stress and cell death. Molecular analyses demonstrated coordinated transcriptional regulation of apoptosis- and cell cycle-related genes, characterized by upregulation of BAX, CDKN1A, and CDKN1B, and downregulation of BCL-2 and CCND1. Notably, spiramide consistently produced stronger cytotoxic and wound-closure inhibitory effects, suggesting a greater contribution of oxidative stress- and apoptosis-associated pathways. Collectively, these findings indicate that hydroquinidine and spiramide disrupt neuroblastoma cell growth through complementary stress- and cell cycle-associated pathways and identify them as promising candidates for further preclinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Department, School of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.
- Histology and Embryology Department, School of Medicine, İstanbul Medipol University, İstanbul 34214, Turkey.
- Molecular Biology and Genetics, Institute of Natural Sciences, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.
- Biophysics Department, School of Medicine, İzmir Bakırçay University, İzmir 35665, Turkey.
- Medical Biology Department, School of Medicine, İzmir Bakırçay University, İzmir 35665, Turkey.
ORCID-Profile: Evren Gümüş, Ezgi Yıldırım
Zitieren
APA
Gümüş, E., Keskin, İ., Yıldırım, E., Kavak, S., & Demircan, T. (2026). Spiramide and Hydroquinidine Inhibit Proliferation and Migration While Promoting Apoptosis and Oxidative Stress in Neuroblastoma Cells. International Journal of Molecular Sciences, 27(14), 6367. https://doi.org/10.3390/ijms27146367
Vancouver
Gümüş E, Keskin İ, Yıldırım E, Kavak S, Demircan T. Spiramide and Hydroquinidine Inhibit Proliferation and Migration While Promoting Apoptosis and Oxidative Stress in Neuroblastoma Cells. International Journal of Molecular Sciences. 2026;27(14):6367. doi:10.3390/ijms27146367
BibTeX
@article{Gm2026,
author = {Gümüş, Evren and Keskin, İlknur and Yıldırım, Ezgi and Kavak, Servet and Demircan, Turan},
title = {Spiramide and Hydroquinidine Inhibit Proliferation and Migration While Promoting Apoptosis and Oxidative Stress in Neuroblastoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6367},
doi = {10.3390/ijms27146367}
}
EUVIMED